ELIXIR Scientific Programme 2019-2023

The scientific direction of ELIXIR is guided by the ELIXIR Scientific Programme -  a strategic document that lays out priorities and objectives for a given five-year programming cycle. The first ELIXIR Scientific Programme covers years 2014-2018 and contains eight strategic objectives.

The second Scientific Programme will set forth the objectives for 2019-2013; the development of this document starts in autumn 2017.

As a strategic document to set forth the future direction of ELIXIR, it has to reflect the priorities and activities of ELIXIR Members and at the same time meet the highest scientific and technical standards. The development will be driven by the ELIXIR Heads of Node Committee, with regular consultation with the ELIXIR Scientific Advisory Board. The final document will then be presented to the ELIXIR Board, the highest decision-making body of ELIXIR.

The development process will kick off at the Heads of Node Committee meeting in September, which will draft a high level vision for ELIXIR in 2023 and prepare a list of priority areas for 2019-2023.

Full timeline for the development of the Scientific Programme is available below (click for larger picture).

For more information, contact Susanna Repo, ELIXIR Programme Manager at susanna.repo[at]elixir-europe[dot]org.

Related news, milestones and upcoming events

  • 12-28 February 2018: First draft of the Programme shared with ELIXIR Community for feedback. View the document.
  • 1-2 February 2018: The ELIXIR SAB reviewed the first draft of the Programme and provided useful feedback to ELIXIR Platforms, Communities and the ELIXIR Heads of Nodes.
  • 21 November 2017: The first draft of ELIXIR 2019-23 Programme has been shared with the Heads of Nodes for initial feedback. This feedback will guide the finalisation of the first draft which will in January be shared with the ELIXIR SAB.
  • 14 November 2017: ELIXIR Board Meeting, 13-14 November 2017, Paris. The Programme vision will be presented to the Board for the first time
  • 29 September 2017: ELIXIR to establish new Use Cases for proteomics, metabolomics and Galaxy